Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGalliford Try Regulatory News (GFRD)

Share Price Information for Galliford Try (GFRD)

Share Price is delayed by 15 minutes
Get Live Data
522.00    -3.00 (-0.57%)
Bid:
524.00
Ask:
526.00
Spread: 2.00 (0.382%)
Market Cap: £512.62m
GFRD Live PriceLast checked at - London Stock Exchange

Intraday Galliford Try Share Chart

Rule 2.8 Announcement

5 Apr 2017 07:00

RNS Number : 5943B
Galliford Try PLC
05 April 2017
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, IN OR INTO OR FROM, ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION.

 

THIS IS AN ANNOUNCEMENT FALLING UNDER RULE 2.8 OF THE CITY CODE ON TAKEOVERS AND MERGERS (THE "CODE").

 

FOR IMMEDIATE RELEASE

 

 

Galliford Try Plc ("Galliford Try" or the "Group")

 

Statement re Bovis Homes Group Plc ("Bovis")

 

 

On 12 March 2017, Galliford Try announced that it had approached the Board of Bovis and proposed an all share merger between Galliford Try and Bovis. Galliford Try now confirms that it is no longer considering a combination with Bovis.

 

Since the approach, the leadership teams of Galliford Try and Bovis have held discussions over a number of weeks that have been largely constructive. It has, however, become clear to the Board of Galliford Try that it is not possible to secure the support of the Board of Bovis on terms that represent the best interests of Galliford Try shareholders.

 

The Board believes that Galliford Try has a strong future based on its current business model. Galliford Try will continue to focus on delivering the five-year organic growth strategy set out at its Capital Markets Day event on 21 February 2017. This strategy is targeting sustainable growth and strong returns across each of Galliford Try's businesses; Housebuilding, Partnerships & Regeneration and Construction. Targets include growth in Group profit before tax to 2021 of at least 60%, a five year compound annual growth rate of dividends of at least 5% and a return on the Group's net assets in 2021 of at least 25%.

 

As a result of this announcement, Galliford Try will, except with the consent of the UK Panel on Takeovers and Mergers, be bound by the restrictions contained in Rule 2.8 of the Code.

 

For the purposes of Rule 2.8 of the Code, Galliford Try reserves the right to announce an offer or possible offer or participate in an offer or possible offer for Bovis and / or take any other action which would otherwise be restricted under Rule 2.8 of the Code within six months after the date of this announcement in the circumstances described in note 2 to Rule 2.8 of the Code.

 

The person responsible for the release of this announcement on behalf of Galliford Try is Kevin Corbett, General Counsel & Company Secretary.

 

Website publication

In accordance with Rule 26.1 of the Code, a copy of this announcement will be published on the Galliford Try website (www.gallifordtry.co.uk) by no later than 12 noon on 6 April 2017. The content of the website referred to in this announcement is not incorporated into and does not form part of this announcement. 

 

- END -

For further information please contact:

 

Tulchan Communications

James Macey White

Martin Pengelley

Matt Low

 

Tel: +44 (0) 207 353 4200

 

Notes to Editors

 

Galliford Try is a leading UK housebuilding, regeneration and construction company listed on the London Stock Exchange with a market cap. of c.£1.3bn. It operates through three divisions:

 

Housebuilding: Linden Homes (which accounted for ~85% of Galliford Try's FY16 operating profit) is the UK's eighth largest housebuilder by completions. It has a landbank of approximately 11,500 plots and operates nationally, with particular strength in the South East.

 

Partnerships and Regeneration: Operates as a contractor and developer and is a key driver of growth for Galliford Try. Capital light business that generates high returns with low levels of risk. In FY16, the division delivered over 2,100 units, with ~25% delivered as private, mixed-tenure properties.

 

Construction: A high quality, UK contractor focused on delivering projects in the public and regulated sectors.

 

For the last financial year to 30 June 2016, Galliford Try reported Group revenue of c.£2.5bn and profit before tax of £135m. Reported return on net assets for the same period was 25.3%.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUGURPCUPMGRC
Date   Source Headline
1st Jun 202610:00 amRNSTotal Voting Rights
29th May 202610:45 amRNSHolding(s) in Company
28th May 20264:10 pmRNSHolding(s) in Company
19th May 20264:00 pmRNSHolding(s) in Company
7th May 20267:00 amRNSInvestor and Analyst Site Visit
1st May 202610:00 amRNSTotal Voting Rights
23rd Apr 202610:30 amRNSReplacement: Completion of Share Buyback Programme
22nd Apr 20267:10 amRNSTransaction in Own Shares
22nd Apr 20267:00 amRNSTransaction in Own Shares
21st Apr 20264:25 pmRNSContract
20th Apr 20267:00 amRNSTransaction in Own Shares
16th Apr 20264:15 pmRNSDirector/PDMR Shareholding
13th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 202610:00 amRNSTotal Voting Rights
30th Mar 20267:00 amRNSTransaction in Own Shares
27th Mar 20262:30 pmRNSDirector/PDMR Shareholding
23rd Mar 20267:00 amRNSTransaction in Own Shares
20th Mar 20267:00 amRNSTransaction in Own Shares
19th Mar 20267:00 amRNSTransaction in Own Shares
18th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
12th Mar 202610:00 amRNSDirector/PDMR Shareholding
4th Mar 20263:00 pmRNSReplacement - Transaction in Own Shares
4th Mar 20267:00 amRNSHalf-year Financial Report
2nd Mar 202610:00 amRNSTotal Voting Rights
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSTransaction in Own Shares
25th Feb 20267:00 amRNSTransaction in Own Shares
24th Feb 20267:00 amRNSTransaction in Own Shares
20th Feb 20267:00 amRNSTransaction in Own Shares
18th Feb 20267:00 amRNSContract
12th Feb 20267:00 amRNSTransaction in Own Shares
11th Feb 20267:00 amRNSTransaction in Own Shares
10th Feb 20267:00 amRNSTransaction in Own Shares
6th Feb 20267:00 amRNSTransaction in Own Shares
5th Feb 20267:00 amRNSTransaction in Own Shares
4th Feb 20267:00 amRNSTransaction in Own Shares
3rd Feb 20267:00 amRNSTransaction in Own Shares
2nd Feb 202610:00 amRNSTotal Voting Rights
2nd Feb 20267:00 amRNSTransaction in Own Shares
30th Jan 20267:00 amRNSTransaction in Own Shares
29th Jan 20267:00 amRNSTransaction in Own Shares
28th Jan 20267:00 amRNSTransaction in Own Shares
27th Jan 20267:00 amRNSTransaction in Own Shares
26th Jan 20267:00 amRNSTransaction in Own Shares
22nd Jan 20267:00 amRNSTransaction in Own Shares
21st Jan 20267:02 amRNSTransaction in Own Shares
21st Jan 20267:00 amRNSTrading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.